Literature DB >> 16227331

Aetiological role of viral and bacterial infections in acute adult lower respiratory tract infection (LRTI) in primary care.

D D Creer1, J P Dilworth, S H Gillespie, A R Johnston, S L Johnston, C Ling, S Patel, G Sanderson, P G Wallace, T D McHugh.   

Abstract

BACKGROUND: Lower respiratory tract infections (LRTI) are a common reason for consulting general practitioners (GPs). In most cases the aetiology is unknown, yet most result in an antibiotic prescription. The aetiology of LRTI was investigated in a prospective controlled study.
METHODS: Eighty adults presenting to GPs with acute LRTI were recruited together with 49 controls over 12 months. Throat swabs, nasal aspirates (patients and controls), and sputum (patients) were obtained and polymerase chain reaction (PCR) and reverse transcriptase polymerase chain reaction (RT-PCR) assays were used to detect Streptococcus pneumoniae, Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella pneumophila, influenza viruses (AH1, AH3 and B), parainfluenza viruses 1-3, coronaviruses, respiratory syncytial virus, adenoviruses, rhinoviruses, and enteroviruses. Standard sputum bacteriology was also performed. Outcome was recorded at a follow up visit.
RESULTS: Potential pathogens were identified in 55 patients with LRTI (69%) and seven controls (14%; p<0.0001). The identification rate was 63% (viruses) and 26% (bacteria) for patients and 12% (p<0.0001) and 6% (p = 0.013), respectively, for controls. The most common organisms identified in the patients were rhinoviruses (33%), influenza viruses (24%), and Streptococcus pneumoniae (19%) compared with 2% (p<0.001), 6% (p = 0.013), and 4% (p = 0.034), respectively, in controls. Multiple pathogens were identified in 18 of the 80 LRTI patients (22.5%) and in two of the 49 controls (4%; p = 0.011). Atypical organisms were rarely identified. Cases with bacterial aetiology were clinically indistinguishable from those with viral aetiology.
CONCLUSION: Patients presenting to GPs with acute adult LRTI predominantly have a viral illness which is most commonly caused by rhinoviruses and influenza viruses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16227331      PMCID: PMC2080713          DOI: 10.1136/thx.2004.027441

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

1.  Detection of Legionella spp. in bronchoalveolar lavage fluids by DNA amplification.

Authors:  B Jaulhac; M Nowicki; N Bornstein; O Meunier; G Prevost; Y Piemont; J Fleurette; H Monteil
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

2.  A multiplex RT-PCR for the detection of parainfluenza viruses 1-3 in clinical samples.

Authors:  J M Corne; S Green; G Sanderson; E O Caul; S L Johnston
Journal:  J Virol Methods       Date:  1999-09       Impact factor: 2.014

3.  Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community.

Authors:  J Macfarlane; W Holmes; P Gard; R Macfarlane; D Rose; V Weston; M Leinonen; P Saikku; S Myint
Journal:  Thorax       Date:  2001-02       Impact factor: 9.139

4.  Infections with viruses, Mycoplasma pneumoniae and bacteria in acute respiratory illness. A study of hospitalized patients, patients treated at home, and healthy subjects.

Authors:  H Fransén; S Wolontis
Journal:  Scand J Infect Dis       Date:  1969-05

5.  Detection of adenovirus in clinical specimens by polymerase chain reaction and liquid-phase hybridization quantitated by time-resolved fluorometry.

Authors:  J C Hierholzer; P E Halonen; P O Dahlen; P G Bingham; M M McDonough
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

6.  Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community.

Authors:  J T Macfarlane; A Colville; A Guion; R M Macfarlane; D H Rose
Journal:  Lancet       Date:  1993-02-27       Impact factor: 79.321

7.  Detection of Chlamydia pneumoniae by polymerase chain reaction.

Authors:  L A Campbell; M Perez Melgosa; D J Hamilton; C C Kuo; J T Grayston
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

8.  Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms.

Authors:  S L Johnston; G Sanderson; P K Pattemore; S Smith; P G Bardin; C B Bruce; P R Lambden; D A Tyrrell; S T Holgate
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

9.  [Acute bronchitis in adults. Clinical findings, microorganisms and use of antibiotics].

Authors:  H Melbye; B P Berdal
Journal:  Tidsskr Nor Laegeforen       Date:  1994-03-10

10.  Acute bronchitis in the community: clinical features, infective factors, changes in pulmonary function and bronchial reactivity to histamine.

Authors:  D A Boldy; S J Skidmore; J G Ayres
Journal:  Respir Med       Date:  1990-09       Impact factor: 3.415

View more
  36 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

Review 2.  South African guideline for the management of community-acquired pneumonia in adults.

Authors:  Tom H Boyles; Adrian Brink; Greg L Calligaro; Cheryl Cohen; Keertan Dheda; Gary Maartens; Guy A Richards; Richard van Zyl Smit; Clifford Smith; Sean Wasserman; Andrew C Whitelaw; Charles Feldman
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

3.  Mycoplasma pneumoniae infection in primary care investigated by real-time PCR in England and Wales.

Authors:  V J Chalker; T Stocki; M Mentasti; D Fleming; C Sadler; J Ellis; A Bermingham; T G Harrison
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-02-12       Impact factor: 3.267

Review 4.  The diagnosis of viral respiratory disease in older adults.

Authors:  H Keipp Talbot; Ann R Falsey
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

5.  Aetiology and prediction of pneumonia in lower respiratory tract infection in primary care.

Authors:  Anette Holm; Joergen Nexoe; Lene A Bistrup; Svend S Pedersen; Niels Obel; Lars P Nielsen; Court Pedersen
Journal:  Br J Gen Pract       Date:  2007-07       Impact factor: 5.386

6.  Tools for detection of Mycoplasma amphoriforme: a primary respiratory pathogen?

Authors:  Clare L Ling; Katarina Oravcova; Thomas F Beattie; Dean D Creer; Paul Dilworth; Naomi L Fulton; Alison Hardie; Michelle Munro; Marcus Pond; Kate Templeton; David Webster; Sarita Workman; Timothy D McHugh; Stephen H Gillespie
Journal:  J Clin Microbiol       Date:  2014-01-29       Impact factor: 5.948

7.  Access to a polymerase chain reaction assay method targeting 13 respiratory viruses can reduce antibiotics: a randomised, controlled trial.

Authors:  Robin Brittain-Long; Johan Westin; Sigvard Olofsson; Magnus Lindh; Lars-Magnus Andersson
Journal:  BMC Med       Date:  2011-04-26       Impact factor: 8.775

8.  Development of a multiplex real-time PCR assay for the simultaneous detection of four bacterial pathogens causing pneumonia.

Authors:  Ho Jae Lim; Eun-Rim Kang; Min Young Park; Bo Kyung Kim; Min Jin Kim; Sunkyung Jung; Kyoung Ho Roh; Nackmoon Sung; Jae-Hyun Yang; Min-Woo Lee; Sun-Hwa Lee; Yong-Jin Yang
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

9.  Impact of positive chest X-ray findings and blood cultures on adverse outcomes following hospitalized pneumococcal lower respiratory tract infection: a population-based cohort study.

Authors:  Marlene Skovgaard; Henrik C Schønheyder; Thomas Benfield; Rikke B Nielsen; Jenny D Knudsen; Jette Bangsborg; Christian Østergaard; Hans-Christian Slotved; Helle Bossen Konradsen; Lotte Lambertsen; Reimar W Thomsen
Journal:  BMC Infect Dis       Date:  2013-05-02       Impact factor: 3.090

10.  Rainforest pharmacopeia in Madagascar provides high value for current local and prospective global uses.

Authors:  Christopher D Golden; B J Rodolph Rasolofoniaina; E J Gasta Anjaranirina; Lilien Nicolas; Laurent Ravaoliny; Claire Kremen
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.